Key Takeaways:
Rosen Law Firm filed a securities class action against Alibaba, giving BABA investors until Oct. 5 to seek lead plaintiff.
The case, Wistisen v. Alibaba Group Holding Ltd., charges the company and its chief executive with violations of the Securities Exchange Act of 1934, Rosen Law Firm said.
The complaint alleges Alibaba was directly or indirectly controlled by or affiliated with China's Ministry of Industry and Information Technology, making it a Chinese military company under the National Defense Authorization Act. It also claims the risk of Alibaba carrying out distillation attacks against third-party AI models was ongoing, not hypothetical or inadvertent.
Alibaba's American depositary shares fell nearly 4 percent after the U.S. Department of Defense added the company to its Chinese military company list on June 8. The stock dropped a further 2.7 percent on June 24 and 4.7 percent on June 25 after Bloomberg reported that Anthropic accused operators linked to Alibaba's Qwen AI lab of illicitly accessing Claude's software engineering and agentic reasoning capabilities.
Investors who purchased Alibaba securities during the class period may be entitled to compensation without out-of-pocket fees through a contingency arrangement. A lead plaintiff, typically the movant with the greatest financial interest in the relief sought, acts on behalf of all class members and can select counsel of its choice.
Robbins Geller Rudman & Dowd LLP separately announced the same class action with the identical Oct. 5 lead plaintiff deadline. The firm said it recovered more than $916 million for investors in 2025, ranking first on the ISS Securities Class Action Services Top 50 Report.
The lawsuit adds to regulatory and legal pressure on Alibaba, whose shares have been weighed by U.S. scrutiny of Chinese technology companies. Investors will watch whether the court certifies the class and how the company responds to the military-company designation and the AI access allegations.
This article is for informational purposes only and does not constitute investment advice.
